Exchange: NASDAQ·Updated 02:15 PM EST
STOK logo

STOK Stoke Therapeutics Inc

$26.87
$0.84
(3.03%)
Today
Reported EarningsOct 29
Mkt Cap$1.81B
Vol429,041.00

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
49

Neutral Sentiment

How do you feel about STOK?

JFais
$STOK - to DD list, $1.4B EV with phase 3 Dravet readout Q3 2027 & initial phase 1 POC data for ADOA 1H 27. Like the TANGO platform tech readthrough to additional indications (moving into cardiac as well)
1
Merlintrader
Stoke Therapeutics $STOK will present at two investor conferences in November. CEO Ian F. Smith and Chief Patient Officer Jason Hoitt present on Nov 10 in Boston (1:00 p.m. ET) and Nov 17 in London (11:00 a.m. ET). Shares closed at $26.48 on Monday, below the SMA50 and below the SMA200, RSI 74. More details in our hub. Not investment advice.
StocktwitsEarnings
$STOK Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.08 down -66.15% YoY • Reported revenue of $11.26M up 5.93% YoY • Stoke Therapeutics said its $358.8M in cash, cash equivalents and marketable securities as of September 30, 2026 is expected to fund operations into early 2028.
shoc24
$STOK reports earnings today after the close. I used Stock Meadow’s earnings dashboard to review its history: STOK has beaten EPS estimates in 5 of its last 8 reports.
TwongStocks
$STOK Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates https://www.businesswire.com/news/home/20261022784889/en/Stoke-Therapeutics-to-Host-Webcast-and-Conference-Call-to-Discuss-Third-Quarter-2026-Business-and-Financial-Updates Management will host a webcast and conference call for analysts and investors on Thursday, October 29, 2026, at 4:30 p.m. ET, to discuss third quarter 2026 business and financial updates.

Advertisement|Remove ads.